CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 2, 1998, Pages 167-170

  Cho Chung, Yoon S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR;

CANCER INHIBITION; CONFERENCE PAPER; CYCLIC AMP RESPONSIVE ELEMENT; GENE THERAPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TUMOR GROWTH;

EID: 0031924958     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.167     Document Type: Conference Paper

References (24)

1. AGADIR, A., SHEALY, Y.F., HILL, D.L., and ZHANG, X. (1997). Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Cancer Res. 57, 3444-3450.
2. AGRAWAL, S., GOODCHILD, J., CIVEIRA, M.P., THORNTON, A.H., SARIN, P.S., and ZAMECNIK, P.C. (1988). Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85, 7079-7083.
3. ARIAS, J., ALBERTS, A.S., BRINDLE, P., CLARET, F.X., SMEAL, T., KARIN, M., FERAMISCO, J., and MONTMINY, M. (1994). Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-229.
4. BIANCHI, M.E., BELTRAME, M., and PAONESSA, G. (1989). Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243, 1056-1059.
5. BIELINSKA, A., SHIVDASANI, R.A., ZHANG, L., and NABEL, G.J. (1990). Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250, 997-1000.
6. BROWN, M., FIGGE, J., HANSEN, U., WRIGHT, C., JEANG, K.-T., KHOURY, G., LIVINGSTON, D.M., and ROBERTS, T.M. (1987). lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell 49, 603-612.
7. COMB, M., MERMOD, N., HYMAN, S.E., PEARLBERG, J., ROSS, M.E., and GOODMAN, H.M. (1988). Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. EMBO J. 7, 3793-3805.
8. CROOKE, S.T. (1992). Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32, 329-376.
9. FRIEDMAN, A.D., TRIEZENBERG, S.J., and MCKNIGHT, S.L. (1988). Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature 335, 452-454.
10. GACY, A.M., and MCMURRAY, C.T. (1994). Hairpin formation within the human enkephalin enhancer region. Kinetic analysis. Biochemistry 33, 11951-11959.
11. GONZALEZ, G.A., and MONTMINY, M.R. (1989). Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680.
12. GU, W., SHI, X.L., and ROEDER, R.G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-823.
13. HU, M.C.-T., and DAVIDSON, N. (1988). The inducible lac operator-repressor system is functional in mammalian cells. Cell 48, 555-566.
14. KWOK, R.P.S., LUNDBLAD, J.R., CHRIVIA, J.C., RICHARDS, J.P., BACHINGER, H.P., BRENNAN, R.G., ROBERTS, S.G.E., GREEN, M.R., and GOODMAN, R.H. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226.
15. MAHER, L.J. III, WOLD, B., and DERVAN, P.B. (1989). Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science 245, 725-730.
16. MCMURRAY, C.T., JURANIC, N., CHANDRASEKARAN, S., MACURA, S., LI, Y., JONES, R.L., and WILSON, W.D. (1994). Hairpin formation within the human enkephalin enhancer region. Structural studies. Biochemistry 33, 11960-11970.
17. MCMURRAY, C.T., WILSON, W.D., and DOUGLASS, J.O. (1991). Hairpin formation within the enhancer region of the human enkephalin gene. Proc. Natl. Acad. Sci. USA 88, 666-670.
18. MORISHITA, R., GIBBONS, G.H., HORIUCHI, M., ELLISON, K.E., NAKAJIMA, M., ZHANG, L., KANEDA, Y., OGIHARA, T., and DZAU, V.J. (1995). A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA 92, 5855-5859.
19. NILSSON, M., FORD, J., BOHM, S., and TOFTGARD, R. (1997). Characterization of a nuclear factor that binds juxtaposed with ATF3/Jun on a composite response element specifically mediating induced transcription in response to an epidermal growth factor/Ras/Raf signaling pathway. Cell Growth Differ. 8, 913-920.
20. ROESLER, W.J., VANDENBARK, G.R., and HANSON, R.W. (1988). Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263, 9063-9066.
21. ROUSH, W. (1997). Antisense aims for a renaissance. Science 276, 1192-1193.
22. WALTON, K.M., REHFUSS, R.P., CHRIVIA, J.C., LOCHNER, J.E., and GOODMAN, R.H. (1992). A dominant repressor of cyclic adenosine 3′,5′-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo. Mol. Endocrinol. 6, 647-655.
23. WANG, X.F., and CALAME, K. (1986). SV40 enhancer-binding factors are required at the establishment but not the maintenance step of enhancer-dependent transcriptional activation. Cell 47, 241-247.
24. ZON, G. (1988). Oligonucleotide analogues as potential-chemotherapeutic agents. Pharmacol. Res. 5, 539-549.